Medicinova INC Form 4 insider transactions

Medicinoa Inc. reports that Director Nagao Hideki acquired 44,500 stock options with an exercise price of $1.36.

Director Nicole Lemerond of Medicinova Inc. acquired 44,500 stock options with an exercise price of $1.36, vesting over four installments.

Director Carolyn Beaver reported the acquisition of stock options for 44,500 shares of Medicinova Inc. common stock.

MedicinoVa's Chief Medical Officer, Kazuko Matsuda, was granted 350,000 stock options which have fully vested due to performance criteria being met.

MEDICINOVA INC's President and CEO, Yuichi Iwaki, was granted 450,000 stock options at an exercise price of $2.1, which fully vested after meeting 2025 performance criteria.

Medicinova Inc. Director Hideki Nagao was granted 20,000 stock options with an exercise price of $1.26, vesting over four installments through June 2026.

Medicilona Inc. Director Nicole Lemerond was granted 20,000 stock options with an exercise price of $1.26, vesting over four installments through June 2026.

Carolyn Beaver, a Director at Medicinova Inc. (MNOV), was granted 20,000 stock options with an exercise price of $1.26, vesting in four equal installments through June 2026.

Director Nagao Hideki acquired stock options in Medicinoiva Inc. on February 12, 2025.

Kazuko Matsuda, Chief Medical Officer and Director at Medicinoiva Inc., reports the acquisition of 100,000 employee stock options.

Director Nicole Lemerond acquired stock options in Medicinoiva, Inc. on February 12, 2025.

Medicinoiva Inc. CEO Yuichi Iwaki reports acquisition of employee stock options.

Director Carolyn Beaver acquired 24,500 stock options in Medicinoiva Inc. on February 12, 2025, exercisable at $1.84, vesting in quarterly installments, and expiring on February 11, 2035.

Medicinoiva's Chief Medical Officer, Kazuko Matsuda, exercised options to purchase 300,000 shares of common stock after performance criteria were met.

Medicinoiva's CEO, Yuichi Iwaki, has acquired 400,000 shares of common stock through the vesting of an employee stock option.

Director Nagao Hideki acquired 20,000 stock options in Medicinoiva Inc. on June 11, 2024.

Director Nicole Lemerond acquired stock options for 20,000 shares of Medicinoiva stock on June 11, 2024.

Director Carolyn Beaver acquired stock options for 20,000 shares of Medicinoiva Inc. on June 11, 2024.